| |
| |
|
| Insider
Information: |
Labarre Michael J. |
| Relationship: |
|
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
168,176 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$8,324,712 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
168,176 |
|
|
| Total
Value |
$8,324,712 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -27.8%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Halozyme Therapeutics Inc |
HALO |
|
2024-05-22 |
168,176 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
106 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-12-21 |
4 |
AS |
$42.54 |
$510,919 |
D/D |
(12,000) |
122,800 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-03-01 |
4 |
AS |
$45.56 |
$839,364 |
D/D |
(18,324) |
122,800 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-04-01 |
4 |
AS |
$42.11 |
$1,221,037 |
D/D |
(28,689) |
122,800 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-02-10 |
4 |
D |
$50.60 |
$147,044 |
D/D |
(2,906) |
128,028 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-02-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,134 |
130,934 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-02-12 |
4 |
D |
$49.84 |
$135,814 |
D/D |
(2,725) |
133,186 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-05-03 |
4 |
OE |
$11.29 |
$127,701 |
D/D |
11,311 |
134,111 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-07-01 |
4 |
AS |
$45.70 |
$1,842,315 |
D/D |
(40,315) |
134,111 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-11-20 |
4 |
AS |
$38.24 |
$465,176 |
D/D |
(12,000) |
134,800 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,883 |
135,911 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-02-14 |
4 |
D |
$49.84 |
$113,236 |
D/D |
(2,272) |
136,685 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2023-02-27 |
4 |
AS |
$49.55 |
$495,483 |
D/D |
(10,000) |
138,927 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,771 |
138,957 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-02-22 |
4 |
D |
$48.69 |
$212,483 |
D/D |
(4,364) |
141,124 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2023-02-27 |
4/A |
AS |
$49.55 |
$147,854 |
D/D |
(2,984) |
141,911 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2023-04-18 |
4 |
AS |
$36.00 |
$360,000 |
D/D |
(10,000) |
141,911 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2023-06-21 |
4 |
AS |
$36.00 |
$360,000 |
D/D |
(10,000) |
141,911 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2023-07-18 |
4 |
AS |
$40.43 |
$404,300 |
D/D |
(10,000) |
141,911 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2023-01-17 |
4 |
AS |
$50.40 |
$504,590 |
D/D |
(10,000) |
143,137 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2023-02-15 |
4 |
AS |
$48.39 |
$483,940 |
D/D |
(10,000) |
143,477 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2023-02-27 |
4/A |
OE |
$18.41 |
$54,935 |
D/D |
2,984 |
144,895 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2021-02-22 |
4 |
OE |
$0.00 |
$0 |
D/D |
8,803 |
145,488 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2023-02-15 |
4 |
D |
$49.20 |
$57,564 |
D/D |
(1,170) |
145,693 |
0 |
- |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, Chief Technical Officer |
• – – |
2020-10-20 |
4 |
AS |
$30.43 |
$365,148 |
D/D |
(12,000) |
146,800 |
0 |
% |
|
| HALO |
Halozyme Therapeutics Inc |
SVP, CHIEF TECHNICAL OFFICER |
• – – |
2023-02-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,386 |
146,863 |
0 |
- |
|
106 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
